January 2014 Clinical Laboratory News: Volume 40, Number 1

CLN Banner Logo


The Search for Improved Markers of Acute Kidney Injury
Will Link Between Kidney Injury and Chronic Disease Drive Research, Clinical Adoption?
By Deborah Levenson

Emerging research shows that acute kidney injury―once thought to be an episode patients generally recover from―actually speeds development and worsening of chronic kidney disease, adding urgency to the need to develop better, earlier biomarkers of acute kidney injury.

Preimplantation Genetic Diagnosis
How Should Labs Grapple With Ethics?
By Karen Appold

Rapidly advancing technology is pushing laboratorians to consider new ethical questions surrounding how preimplantation genetic diagnosis should be used.


Sports Drug Testing Laboratories
Testing Methods to Detect Doping
By Anthony W. Butch, PhD

The International Olympic Committee created the World Anti-Doping Agency (WADA) in 1999 to combat the mounting problem of sports doping and to harmonize all anti-doping principles. While anti-doping testing is a niche specialty, all laboratorians should be aware of the methods used by WADA-accredited laboratories to identify athletes who use prohibited substances.


Severe Pre-eclampsia on the Rise


AACC Calls for Uniformity in Lab Test Results
Harmonization Essential to Improving Patient Care

AACC has released a position statement on harmonization of clinical laboratory test results to help patients receive appropriate diagnoses and medical treatment. In this statement, the association provides guidance on how medical community stakeholders can contribute to the worldwide harmonization initiative.


Reducing Errors in Manual Processes
When We Can't Automate, What's the Best Way to Reduce Errors?
By Mike Astion, MD, PhD

To avoid errors when performing manual processes, it is important for labs to implement steps to create a quiet, calm work environment while also improving standardization and accountability.

The Google Factor
Are the Worried Well Making Healthcare Sick?
By Mike Astion, MD, PhD

The Internet has contributed to overtesting by raising alarm for patients about innocuous symptoms. Diagnostic tests perform poorly when it is unlikely that a patient has the disease being tested for, though, and ordering too many lab tests wastes healthcare resources and can even lead to patient harm.

Quality and the Sendout Testing Department
Get Sendout Processes Under Control to Improve Quality, Efficiency, and Patient Safety
By Sue Garr, BS, MT(ASCP)

To prevent quality lapses during the complex sendout testing process, labs should maintain a robust management program to cope with a large test menu, the unique specimen requirements for each of those tests, and the various shipping and information handling processes expected by reference laboratories.


Regulatory Profiles
Industry Profiles
Diagnostic Profiles
News From the FDA

Page Access:
Interactive Digital Edition

CLN cover

Download the entire issue

Next Month

New Cardiovascular Risk Assessment Guidelines

Regulating Research-Use-Only Tests